Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.290
+0.030 (2.38%)
At close: Jun 23, 2025, 4:00 PM
1.300
+0.010 (0.78%)
After-hours: Jun 23, 2025, 5:42 PM EDT
Akoya Biosciences Market Cap
Akoya Biosciences has a market cap or net worth of $64.34 million as of June 23, 2025. Its market cap has decreased by -35.19% in one year.
Market Cap
64.34M
Enterprise Value
120.52M
1-Year Change
-35.19%
Ranking
Category
Stock Price
$1.29
Market Cap Chart
Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $64.34M, a decrease of -90.99%. That is a compound annual growth rate of -43.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 62.84M | -44.63% |
| Dec 31, 2024 | 113.50M | -52.61% |
| Dec 29, 2023 | 239.49M | -34.07% |
| Dec 30, 2022 | 363.24M | -36.24% |
| Dec 31, 2021 | 569.65M | -20.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.73B |
| Johnson & Johnson | 360.41B |
| AbbVie | 327.31B |
| Novo Nordisk | 326.28B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 231.38B |
| Novartis AG | 227.54B |
| AstraZeneca | 217.06B |